Learn, Analyse & Invest
only with

+91

Download Orca

To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Laurus Labs Ltd.

Laurus Labs

₹ 0.00

0.00 (0.00)%

NSE

BSE

Healthcare

Mid-cap - With a market cap of ₹447.58 Cr.

EX-Date	Purpose
29 04 2021	Third Interim Dividend & Audited Results
29 07 2021	Quarterly Results
28 10 2021	Quarterly Results & Interim Dividend
27 01 2022	Quarterly Results
28 04 2022	Interim Dividend & Audited Results
27 07 2022	Quarterly Results
21 10 2022	Quarterly Results & Interim Dividend
30 01 2023	Quarterly Results
27 04 2023	Second Interim Dividend & Audited Results
27 07 2023	Quarterly Results
20 10 2023	Quarterly Results & Interim Dividend
24 01 2024	Quarterly Results
24 10 2024	Quarterly Results & Interim Dividend
24 04 2025	Interim Dividend & Audited Results
25 07 2025	Quarterly Results

News

02-MAY-2023

Laurus Labs gets USFDA’s tentative approval for Oral Dispersible Film Dolutegravir

his innovative paediatric drug administration through Oral Dispersible Film technology developed by Laurus Labs will simplify the drug administration in children

05:52 PM

09-DEC-2024

Laurus Labs’ arm secures equity investments from Eight Roads Ventures, F-Prime Capital, Laurus Labs

The Promoters of Laurus Bio have also been issued share warrants

10:50 AM

12-SEP-2023

Laurus Labs to acquire stake in Laurus Bio

With this acquisition, the shareholding of the Company in Laurus Bio will become 87.58% on fully diluted basis

09:49 AM

13-DEC-2023

USFDA inspects Andhra Pradesh facility of Laurus Labs’ arm

The inspection was conducted from December 4, 2023 to December 12, 2023

10:41 AM

14-SEP-2024

Laurus Labs completes USFDA Audit for API Manufacturing Facility at Hyderabad

The audit concluded with zero Form 483 observations

04:47 PM

15-APR-2025

Laurus Labs gets EIR for API manufacturing facility in Andhra Pradesh

The USFDA inspection was conducted from January 27, 2025 to January 31, 2025

02:18 PM

15-JUN-2023

Laurus Labs gets EIR from USFDA for Andhra Pradesh manufacturing facility

Earlier, USFDA had conducted inspection at the said manufacturing unit from February 06, 2023 to February 10, 2023

05:54 PM

16-SEP-2024

Laurus Labs inaugurates new R&D facility

The 2,00,000 square foot facility is equipped with modern laboratories and infrastructure

02:59 PM

17-MAR-2025

Laurus Labs acquires equity shares in KRKA

The company has invested Rs 83.30 crore

11:22 AM

19-FEB-2024

Laurus Labs invests over Rs 99 crore in subsidiary

The Company has infused further equity via rights issue keeping in view of the funds requirements of LSPL

12:13 PM

19-JUN-2023

Laurus labs inks pact with IIT Kanpur

As per MOA, Laurus labs will in-license few gene therapy assets and will provide research grant for advancing these products through the pre-clinical development

12:15 PM

20-OCT-2023

Laurus Labs reports 83% fall in Q2 consolidated net profit

Total consolidated income of the company decreased by 22.24% at Rs 1226.23 crore for Q2FY24

03:44 PM

21-NOV-2023

Laurus Labs acquires additional stake in Laurus Bio

With this acquisition the Company holds 87.59% shareholding (on fully diluted basis) in Laurus Bio

10:30 AM

23-JAN-2025

Laurus Labs’ arm gets one observation from USFDA

Laurus Generics Inc. has undergone a Post-marketing Adverse Drug Experience inspection by USFDA

11:58 AM

25-NOV-2022

Laurus Labs enters into share subscription agreement with Ethan Energy India

This will enable the Company to consume 100% of the solar energy to be supplied by Ethan Energy India from their 10 MW Solar Energy plant

10:07 AM

26-JUN-2025

Laurus Labs invests Rs 39.99 crore in Laurus Bio

The company has acquired Series A2 Compulsorily Convertible Preference Shares of Laurus Bio at face value of Rs 100 and premium of Rs 25,850.02

03:08 PM

27-JUL-2023

Laurus Labs reports 89% fall in Q1 consolidated net profit

Total consolidated income of the company decreased by 23.06% at Rs 1,185.39 crore for Q1FY24

04:13 PM

28-APR-2023

Laurus Labs reports 54% fall in Q4 consolidated net profit

Total consolidated income of the company decreased by 3.05% at Rs 1,382.61 crore for Q4FY23

12:38 PM

28-MAR-2025

Laurus Labs gets nod to acquire up to 26% stake in Kurnool Renewables

The investment by the company is expected to be completed within a period of 1 year in three stages

04:40 PM

29-JAN-2024

Laurus Labs enters into joint venture agreement with Krka

In this JV Company, Krka will hold 51% and Laurus 49% shareholding

12:41 PM

29-OCT-2022

USFDA completes pre-approval inspection at Laurus Labs’ facility in Andhra Pradesh

The company has been issued a Form 483 with one observation

12:40 PM

30-JAN-2023

Laurus Labs reports 31% rise in Q3 consolidated net profit

Total consolidated income of the company increased by 49.53% to Rs 1,546.25 crore for the quarter under review

04:00 PM